Altamira Therapeutics Ltd - Warrants (29/03/2028) Total Liabilities

As of the most recent data (December 2024), CYTOW shows a total liabilities of $2.1M. That compares with $1.2M in the prior-year period — up 68.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYTOW's total liabilities is now $2.1M (was $1.2M) — a 68.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Altamira Therapeutics Ltd - Warrants (29/03/2028) is outperforming or lagging.

Tracking CYTOW's total liabilities over time shows whether Altamira Therapeutics Ltd - Warrants (29/03/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $2.1M That compares with $1.2M in the prior-year period — up 68.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Altamira Therapeutics Ltd - Warrants (29/03/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $2.1M) with ownership activity and broader fundamentals.

Altamira Therapeutics Ltd - Warrants (29/03/2028)'s total liabilities is $2.1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.